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P216 ABSTRACT WITHDRAWN
P217 CLINICAL EFFICACY OF COMPLEX PHYTOPREPARATION
BASED ON EVENING PRIMROSE, GENTIAN, ELDER,
SORREL, VERBENA AS A THERAPEUTIC AGENT IN
TREATMENT OF ACUTE VIRAL RHINOSINUSITIS IN
CHILDREN
1Galyna Beketova*, 2Vasyl Popovich, 3Oleksandr Abaturov, 4Tetyana Kryuchko,
5Olga Tsodikova, 6Lyudmyla Vakulenko. 1Schupyk National Medical Academy of
Postgraduate Education, Kyiv, Ukraine; 2Ivano-Frankivsk National Medical University, Ivano-
Frankivsk, Ukraine; 3Dnipropetrovsk Medical Academy, Dnipro, Ukraine; 4Ukrainian Medical
Stomatological Academy, Poltava, Ukraine; 5Kharkov Medical Academy of Postgraduate
Education, Kharkov, Ukraine; 6Department of Hospital Pediatrics №1, Dnipro, Ukraine
10.1136/archdischild-2019-epa.569
Trial objective/hypothesis Investigation of the benefits of treat-
ment of acute viral RS with complex phytopreparation as a
basic therapeutic agent in contrast to routine therapy based on
the symptomatic treatment.
Products Complex phytopreparation syrup BNO 1012
Trial design Clinical, Non-interventional, Multicentre (5 clinical
centres in four cities), Prospective, Randomized, Comparative
Subjects Patients diagnosed with acute viral RS (n=169): Age:
6–11, average age 8.1; Sex: male (n=88)/female (n=81); The
main group (n=94); The comparison group (n=76)
Inclusion criteria Acute viral RS; First 48 hours since onset of
the disease; Severity of symptoms – 8 to 12 points on the
MSS scale: nasal discharge, nasal congestion, post-nasal drip,
headache, facial pain (0–4 points).
Exclusion criteria Administration of complex phytopreparation
for 30 days prior to the episode; Patients diagnosed with
allergic rhinosinusitis; Known intolerance to primrose drugs;
More than 48 hours since onset of the disease; Severe acute
disease requiring hospitalization/treatment with antibiotics;
Chronic pathology and anatomical anomalies in osteomeatal
complex, which may influence outcome of the disease.
Primary/Secondary efficacy criteria
Decrement of RS symptoms on the MSS scale; Recovery
day / Reduction in frequency of transition to post-viral RS
stage; Reduction in frequency of transition to purulent RS
stage
Duration of treatment 14 days.
Physical examination Visit 1 (day 0); Visit 2 (day 5); Visit 3
(day 10); Visit 4 (day 14)
Patient’s self-evaluation daily for 10 days.
Conclusions Administration of complex preparation for treat-
ment of acute viral RS among children at the age of 6–11
leads to: Substantial decrement of RS symptoms on the MSS
scale starting with visit 2; There was no statistical difference
between groups in terms of dynamics of ‘facial pain’ and
‘headache’ criteria, due to the toxic effects of the viral infec-
tion; Reduction of duration of disease by almost 24 hours;
Substantial reduction in frequency of transition of acute viral
RS to post-viral RS stage (by 79.5%) and bacterial RS stage
(by 58.7%).
P218 ABSTRACT WITHDRAWN
P219 TEENAGE PREGNANCY IN OUR MODERN WORLD
Claire Thompson*, Siobhan McCormack, Rishi Watson, Peter O’ Reilly, Husnain Mahomed,
Anne-Marie Murphy. Department of Paediatrics and Neonatology, University Hospital
Limerick and University Maternity Hospital Limerick, Limerick, Ireland
10.1136/archdischild-2019-epa.570
Background Teenage pregnancy is a major public health con-
cern. As per the WHO, 16 million females between the ages
of 15–19 years and 1 million <15 years of age, give birth
per year.
Complications resulting from pregnancy remain the second
most common cause of death in teenage females (McCarthy F,
O’ Brien U, and Kenny LC, BMJ 2014;349)
A 2016 census (Paul Partnership Limerick 2016) reported a
fifth of Limerick’s total population to live in areas of signifi-
cant socio-economic disadvantage with higher lone and teen-
age pregnancy rates. While the lone parent rate is sited as
21% in Limerick as a whole, this study reports 12 areas
within Limerick where the rate is in excess of 50%.
As such, it is evident that teenage pregnancy is a significant
issue in Limerick, and one which is currently under-researched
and underfunded.
Aim In this retrospective study we aim to examine the data
pertaining to the cohort of teenage mothers presenting to Uni-
versity Maternity Hospital Limerick (UMHL) over the past ten
year period, to analyse numbers presenting, the age of concep-
tion and delivery, and the neonatal morbidity associated with
these pregnancies.
Methods Hospital electronic databases were used to collate
demographic data in relation to teenage pregnancies. Our
study is part of a wider project looking at health and disease
in the adolescent population in our region with a view to
appropriate future planning to services, and provision of heath
care for this cohort.
Results The mean age of conception was determined to be
15.6 years, with no significant deviation over the ten year
period. Mean age of delivery was 16.3 years. On average, this
cohort presented 1.5 times to the Maternity Unit for assess-
ment over the course of their pregnancy, This number has
increased since 2014 to a mean of 1.8 visits, perhaps reflect-
ing a greater uptake of dedicated services. Approximately 2
admissions per month to UMHL are of 14–16 year old ado-
lescent girls.
Discussion These findings highlight the impact of pregnancy
on young teenagers. It is hope to further expand this study to
analyse data relating to neonatal outcome in this group, NICU
admissions and sequelae of same.
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